Skip to main content
Screener/Healthcare/Drug Manufacturers - Specialty & Generic

RGC — Regencell Bioscience Holdings Limited

NASDAQ
$29.70+1.25 (+4.40%)
Large CapUnder $50HealthcareFastest GrowingHigh Beta
$0.72
$83.60
$27.25
$30.00
EPS (TTM)$-0.14
P/E Ratio—
Dividend Yield—
Market Cap$14.04B
Volume130K
Prev Close$28.40
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$1.7M$-0.00——
Q2 '25$0-$1.9M$-0.14——
Q4 '24$0-$1K$0.00——
Q2 '24$0-$1K$-0.00——
Q4 '23$0-$2.6M$-0.01——
Q2 '23$0-$3.2M$-0.01——
Q4 '22-$2.3B-$3.9M$-0.01100.0%0.2%
Q2 '22$0-$3.7M$-0.01——
Get Your Daily Market Recap